Evidence map›Paper›PMID 28068307›Full record

ArticleNature immunology2017

Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10.

Hamida Hammad, Matthias Vanderkerken, Philippe Pouliot, Kim Deswarte, Wendy Toussaint, Karl Vergote, Lana Vandersarren, Sophie Janssens, Ioanna Ramou, Savvas N Savvides and 8 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Activated PIK3CD drives marginal zone B cell development from early transitional progenitors by enhancing ADAM10 expression.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  10. Article
  11. Article
  12. Glycan-Reactive Innate-like B Cells and Developmental Checkpoints.Journal of immunology (Baltimore, Md. : 1950) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Hamida HammadVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Matthias VanderkerkenVIB Inflammation Research Center, Ghent University, Ghent, Belgium.ORCID 0000-0002-0785-5904
Philippe PouliotVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Kim DeswarteVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Wendy ToussaintVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Karl VergoteVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Lana VandersarrenVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Sophie JanssensVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Ioanna RamouVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Savvas N SavvidesVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Jody J HaighVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Rudi HendriksDepartment of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Manfred KopfInstitute for Molecular Health Sciences, ETH, Zürich, Switzerland.
Katleen CraessaertsVIB Center for Brain and Disease, VIB, Leuven, Belgium.
Bart de StrooperVIB Center for Brain and Disease, VIB, Leuven, Belgium.
John F KearneyDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Daniel H ConradCenter for Clinical and Translational Research, Virginia Commonwealth University, Richmond, Virginia, USA.
Bart N LambrechtVIB Inflammation Research Center, Ghent University, Ghent, Belgium.
Ghent University Hospital · BEGhent University · BEVIB-KU Leuven Center for Brain & Disease Research · BEErasmus MC · NLETH Zurich · CHUniversity of Alabama at Birmingham · USVirginia Commonwealth University · US

Funding

Regulation of B cell Clonal Diversity and Its Role in DiseaseR01AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 1985 to 2020
$7.1M
Effects of neonatal microbial exposure on anti-polysaccharide B cell developmentR01AI100005 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2012 to 2016
$1.8M
Medical Research Council MC_PC_17116NIAID NIH HHS R01 AI014782NIAID NIH HHS R01 AI100005
6 · The paper itself

Abstract

Notch2 and B cell antigen receptor (BCR) signaling determine whether transitional B cells become marginal zone B (MZB) or follicular B (FoB) cells in the spleen, but it is unknown how these pathways are related. We generated Taok3

Indexed as

Adaptive ImmunityCell DifferentiationCell LineageADAM10 ProteinAmyloid Precursor Protein SecretasesAnimalsB-LymphocytesCells, CulturedClonal Selection, Antigen-MediatedGene Expression RegulationGerminal CenterIntracellular Signaling Peptides and ProteinsMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutADAM10 ProteinAdam10 protein, mouseAmyloid Precursor Protein SecretasesDll3 protein, mouseIntracellular Signaling Peptides and ProteinsMembrane ProteinsNotch2 protein, mouseProtein Serine-Threonine KinasesReceptor, Notch2Receptors, Antigen, B-CellTack3 kinase, mouse

Identifiers

PMID28068307
OpenAlexW2568714707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.